Protagen AG Achieves ISO 13485 Certification
News Jun 24, 2015
Protagen AG, a company concerned with the development of advanced diagnostic tools to address some of the most severe autoimmune diseases, has received the ISO 13485 certification, and now officially complies with the internationally recognized quality standard for medical devices.
The certificate demonstrates that Protagen has successfully implemented a quality management system that conforms to the world-wide standard for medical device and diagnostic manufacturing.
Stefan Müllner, Protagen CEO, stated, "We have been ISO 9001 certified for some years now. The addition of the new ISO 13485 certification clearly shows our continued commitment to the highest level of quality management and design controls. This guarantees the development and production of safe and effective products and services and our international customer base can be assured that the products we are delivering are of the highest standards. The ISO 13485 criteria will provide a quality foundation upon which we and our partners will develop new diagnostic products."
The ISO (International Organization for Standardization) is the world's largest developer and publisher of International Standards. Receipt of ISO 13485 certification confirms Protagen's ongoing commitment to meeting the requirements of its customers and regulatory bodies.
New Software Allows Mobile Monitoring of Breathing ProblemsNews
Researchers have developed new software that makes it possible to use low-cost, thermal cameras attached to mobile phones to track how fast a person is breathing.READ MORE
Agilent Announces Expanded Use of Cancer Diagnostic in the USNews
Agilent announced that the FDA has approved the cancer diagnostic known as PD-L1 IHC 28-8 pharmDx for use in cases of urothelial carcinoma (UC) and of squamous cell carcinoma of the head and neck (SCCHN).READ MORE
Blood Test for Colitis Screening Could Reduce Dependence on ColonoscopyNews
A fast, simple blood test for ulcerative colitis using infrared spectroscopy could provide a cheaper, less invasive alternative for screening compared to colonoscopy, which is now the predominant test.READ MORE
Comments | 0 ADD COMMENT
13th Edition of International Conference on Pediatric Gastroenterology
Aug 02 - Aug 04, 2018